SEC Company Response from GLOBAL MED TECHNOLOGIES INC (CIK 0001009463) — May 11, 2005

GLOBAL MED TECHNOLOGIES INC (CIK 0001009463)
Date: May 11, 2005 · CIK: 0001009463 · Accession: 0001021890-05-000069

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-123378

Date

March 16, 2005

Author

/s/

Form

CORRESP

Company

GLOBAL MED TECHNOLOGIES INC (CIK 0001009463)

Letter

Global Med Technologies, Inc.--Request for Acceleration Letter

GLOBAL MED TECHNOLOGIES, INC.

12600 West Colfax, Suite C-240

Lakewood, Colorado 80215

(303) 238-2000

May 11, 2005

Securities and Exchange Commission 450 Fifth Street, N.W. Judiciary Plaza

Washington, D.C. 20549

Re:

Global Med Technologies, Inc. Request for Acceleration of Registration Statement on Form S-1

File No. 333-123378

Ladies and Gentlemen:

Global Med Technologies, Inc. (the “Company”) hereby requests acceleration of the effectiveness of its Registration Statement on Form S-1 (File No. 333-123378), filed on March 16, 2005 to 10:00 am on May 13, 2005, or as soon thereafter as practicable.

Please direct any questions or comments regarding this filing to Ronald S. Haligman at (305) 539-3339 or Clayton E. Parker at (305) 539-3306 of Kirkpatrick & Lockhart Nicholson Graham, LLP, counsel to the Company.

Sincerely,
/s/
Michael I. Ruxin

Show Raw Text

CORRESP
1
filename1.htm

Global Med Technologies, Inc.--Request for Acceleration Letter

GLOBAL
MED TECHNOLOGIES, INC.

12600 West Colfax, Suite C-240

Lakewood, Colorado 80215

(303) 238-2000

May
11, 2005

Securities
and Exchange Commission
450 Fifth Street, N.W.
Judiciary Plaza

Washington, D.C.  20549

     Re:

     Global
Med Technologies, Inc.
Request for Acceleration of Registration Statement on Form S-1

File No. 333-123378

Ladies and
Gentlemen:

     Global
Med  Technologies,  Inc. (the “Company”)  hereby requests  acceleration
of the effectiveness of its  Registration  Statement on Form S-1 (File No. 333-123378),
filed on March 16, 2005 to 10:00 am on May 13, 2005, or  as soon thereafter as
practicable.

     Please
direct any questions or comments regarding this filing to Ronald S. Haligman at
(305) 539-3339 or Clayton E. Parker at (305) 539-3306 of Kirkpatrick &
Lockhart Nicholson Graham, LLP, counsel to the Company.

     Sincerely,

/s/
Michael I. Ruxin

Dr. Michael I. Ruxin
Chief Executive Officer

SecProbe.io